|
Index of reports
> Cases resulting in disability (7)
> Cases with Deep Vein Thrombosis (3)
Below is the selection of adverse event reports related to Premarin (Conjugated Estrogens) that includes cases resulting in disability where reactions include deep vein thrombosis.
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-10-30
Patient: 53 year old female, weighing 56.8 kg (124.9 pounds)
Adverse reactions / side effects: Deep Vein Thrombosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Premarin
Dosage: oral
Administration route: Oral
Indication: Menopause
Start date: 1997-02-01
End date: 1997-12-01
Prempro
Other drugs received by patient: Monopril
Adverse event in 53 year old female receiving Premarin (Conjugated Estrogens)
Reported by a physician from United States on 2007-10-30
Patient: 53 year old female, weighing 56.8 kg (124.9 pounds)
Adverse reactions / side effects: Deep Vein Thrombosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Premarin
Dosage: oral
Administration route: Oral
Indication: Menopause
Start date: 1997-02-01
End date: 1997-12-01
Prempro
Other drugs received by patient: Monopril
Adverse event in 57 year old female receiving Premarin (Conjugated Estrogens)
Reported by a individual with unspecified qualification from United States on 2007-03-23
Patient: 57 year old female, weighing 87.1 kg (191.6 pounds)
Adverse reactions / side effects: Peripheral Coldness, Atelectasis, Wound Infection Staphylococcal, Groin Pain, Thrombophlebitis Superficial, Oedema Peripheral, Wound Infection Bacterial, Arteriosclerosis, Aneurysm Repair, Cardiac Failure Congestive, Peripheral Artery Aneurysm, Thrombectomy, Erythema Nodosum, Arterial Bypass Operation, Limb Discomfort, Arthralgia, Intermittent Claudication, Iliac Artery Occlusion, Peripheral Arterial Occlusive Disease, Gait Disturbance, Escherichia Infection, Hypertension, Deep Vein Thrombosis
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Estraderm
Indication: Hormone Replacement Therapy
Start date: 1990-07-13
End date: 1996-01-01
Premarin
Dosage: 0.625 mg, qd
Administration route: Oral
Indication: Hormone Replacement Therapy
Prempro
Indication: Hormone Replacement Therapy
Start date: 1996-01-01
End date: 2002-06-03
Other drugs received by patient: Synthroid; Naprosyn; Aspirin; Aspirin
|
